文献速递癫痫

家族性内侧颞叶癫痫:临床谱系与多基因架构的遗传学证据

Familial Mesial Temporal Lobe Epilepsy: Clinical Spectrum and Genetic Evidence for a Polygenic Architecture.
PubMed 文献 · Ann Neurol · 2023-08-31

本研究分析了134个家族性内侧颞叶癫痫(FMTLE)家系,发现最常见发作症状为似曾相识感(62%),多数为药物反应良好的轻症。FMTLE病例的局灶性癫痫多基因风险评分高于人群对照(OR=1.24,95%CI 1.06-1.46,p=0.007),而热性惊厥多基因风险评分无富集,支持FMTLE的多基因遗传基础。

要点

  • FMTLE起病年龄范围2.5至70岁(中位18岁,IQR 13-28岁),最常见症状为似曾相识感(62%)。
  • FMTLE病例局灶性癫痫PRS高于人群对照(OR=1.24,95%CI 1.06-1.46,p=0.007),热性惊厥PRS无富集。
  • FMTLE总体为药物反应良好的轻症综合征,罕见药物难治和/或海马硬化病例。

核心结论

  • FMTLE是一种总体轻度的药物反应性综合征,似曾相识感为最常见症状。
  • 与显性单基因局灶性癫痫综合征不同,分子数据支持FMTLE的多基因基础。
  • PRS数据提示亚全基因组显著水平的局灶性癫痫GWAS单核苷酸多态性是FMTLE的重要风险变异。

研究设计与样本

  • 研究纳入134个家系,要求至少2名一级或二级亲属患颞叶癫痫,且至少1人具有明确内侧发作症状学。
  • 对227例FMTLE病例、124名未患病亲属和16077名人群对照计算多基因风险评分(PRS)。

主要发现

  • FMTLE患者起病年龄范围为2.5至70岁(中位=18,四分位距=13-28岁)。
  • 最常见局灶性发作症状为似曾相识感(62%),其次为上腹部上升感(34%)、恐惧或焦虑(22%)。
  • 临床谱系包括罕见药物难治和/或海马硬化病例。
  • FMTLE病例的平均局灶性癫痫PRS高于人群对照(OR=1.24,95%CI 1.06-1.46,p=0.007)。
  • 未观察到热性惊厥PRS的富集。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Familial mesial temporal lobe epilepsy (FMTLE) is an important focal epilepsy syndrome; its molecular genetic basis is unknown. Clinical descriptions of FMTLE vary between a mild syndrome with prominent déjà vu to a more severe phenotype with febrile seizures and hippocampal sclerosis. We aimed to refine the phenotype of FMTLE by analyzing a large cohort of patients and asked whether common risk variants for focal epilepsy and/or febrile seizures, measured by polygenic risk scores (PRS), are enriched in individuals with FMTLE. METHODS: We studied 134 families with ≥ 2 first or second-degree relatives with temporal lobe epilepsy, with clear mesial ictal semiology required in at least one individual. PRS were calculated for 227 FMTLE cases, 124 unaffected relatives, and 16,077 population controls. RESULTS: The age of patients with FMTLE onset ranged from 2.5 to 70 years (median = 18, interquartile range = 13-28 years). The most common focal seizure symptom was déjà vu (62% of cases), followed by epigastric rising sensation (34%), and fear or anxiety (22%). The clinical spectrum included rare cases with drug-resistance and/or hippocampal sclerosis. FMTLE cases had a higher mean focal epilepsy PRS than population controls (odds ratio = 1.24, 95% confidence interval = 1.06, 1.46, p = 0.007); in contrast, no enrichment for the febrile seizure PRS was observed. INTERPRETATION: FMTLE is a generally mild drug-responsive syndrome with déjà vu being the commonest symptom. In contrast to dominant monogenic focal epilepsy syndromes, our molecular data support a polygenic basis for FMTLE. Furthermore, the PRS data suggest that sub-genome-wide significant focal epilepsy genome-wide association study single nucleotide polymorphisms are important risk variants for FMTLE. ANN NEUROL 2023;94:825-835.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Harris RV, Oliver KL, Perucca P, et al. Familial Mesial Temporal Lobe Epilepsy: Clinical Spectrum and Genetic Evidence for a Polygenic Architecture. Ann Neurol. 2023. PMID: 37597255. doi:10.1002/ana.26765

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。